GHIC and KfW launch Catalytic Health Investment Platform
October 3, 2024
FRANKFURT, GERMANY / NEW YORK, NEW YORK, 3 October 2024: KfW Development Bank (KfW) and the Global Health Investment Corporation (GHIC) are pleased to announce the launch of the Catalytic Heath Investment Platform (CHIP), a twenty-year partnership between GHIC and the Government of Germany, through its Federal Ministry for Economic Cooperation and Development (BMZ) and KfW, to accelerate the development of public health technologies and products to improve global health with an initial funding commitment of up to €60M.
Building on their existing partnership, KfW and GHIC will continue to expand the GHIC model for innovative impact investment to catalyze health innovations that are responsive to the needs of people in low- and middle-income countries (LMICs). CHIP will pursue investment and grant-making opportunities with significant public health impact potential, including those relevant to health and health system resilience in LMICs. By advancing research and development, investing in technologies and products, expanding access pathways, and connecting global health to market economics, CHIP will engage diverse sectors of the health enterprise to deliver better health outcomes and health systems. The mission and goals of the platform align with Triple I for Global Health, a G7 global health impact initiative to which GHIC and KfW are contributing partners.
BMZ and KfW have been key strategic partners since GHIC’s formation over a decade ago by providing core funding to support GHIC efforts to catalyze investment in the field of global health product development. BMZ and KfW have provided support for GHIC’s investments in the Global Health Investment Fund (GHIF), Adjuvant Global Health Technology Fund, the Women’s and Children’s Health Technology Fund and most recently, the CHIP program.
GHIC’s initial investment fund, GHIF, was launched in 2012 to focus on developing products and tools to address high burden diseases in LMICs. GHIF was conceived of and supported by several of the world’s leading public health institutions, including the Bill & Melinda Gates Foundation, BMZ/KfW, and other leading global health stakeholders and impact investors. GHIF’s investment portfolio, consisting of twelve companies and non-profit organizations, has successfully advanced 16 products to registration and commercialization, improving the lives of tens of millions of people globally.
GHIC welcomes inquiries from managers of investment funds strategically aligned with the investment goals of CHIP. Contact CHIP@ghicfunds.org for further information.
About KfW and BMZ
KfW Development Bank is a German state-owned investment and development bank that finances development projects and programs in LMICs on behalf of the German Federal Government and with support from the German Federal Ministry for Economic Cooperation and Development (“BMZ”).
BMZ works in cooperation with the international community to shape a positive, global future and to reach the Sustainable Development Goals (SDGs) that improve the living conditions for people in LMICs.
For more information, please visit
https://www.kfw-entwicklungsbank.de/International-financing/KfW-Entwicklungsbank/
https://www.kfw-entwicklungsbank.de/SDG-portal/SDG-3/Health-fund/
About GHIC
GHIC, a nonprofit organization, has been investing in global health innovation for over a decade. GHIC seeks to catalyze the development of technologies to improve global health through investments in vaccines, therapeutics, diagnostics, medical devices, and other technologies to save and improve lives, by mobilizing private, public, and philanthropic capital via innovative partnership models.
GHIC leverages the engagement, networks, and funding of its strategic partners and stakeholders to drive innovation, and invest in innovative health technologies for a healthier, safer world.
For more information, please visit www.ghicfunds.org